Ibrance

List of products in the National Drug Code with proprietary name ibrance. Palbociclib is used to treat a certain type of breast cancer. It works by slowing or stopping the growth of cancer cells.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0069-0187Ibrance PalbociclibCapsuleOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-0188Ibrance PalbociclibCapsuleOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-0189Ibrance PalbociclibCapsuleOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-0284Ibrance PalbociclibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-0486Ibrance PalbociclibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-0688Ibrance PalbociclibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
63539-187Ibrance PalbociclibCapsuleOralU.s. PharmaceuticalsHuman Prescription Drug
63539-188Ibrance PalbociclibCapsuleOralU.s. PharmaceuticalsHuman Prescription Drug
63539-189Ibrance PalbociclibCapsuleOralU.s. PharmaceuticalsHuman Prescription Drug
63539-284Ibrance PalbociclibTablet, Film CoatedOralU.s. PharmaceuticalsHuman Prescription Drug
63539-486Ibrance PalbociclibTablet, Film CoatedOralU.s. PharmaceuticalsHuman Prescription Drug
63539-688Ibrance PalbociclibTablet, Film CoatedOralU.s. PharmaceuticalsHuman Prescription Drug